Growth differentiation factor 15 (GDF15) is receiving great interest beyond its role as an aging and disease-related biomarker. Recent discovery of its receptor, glial cell line-derived neurotrophic factor (GDNF) family receptor α-like (GFRAL), suggests a central role in appetite regulation. However, there is also considerable evidence that GDF15 may have peripheral activity through an as-of-yet undiscovered mode of action. This raises the question as to whether increased GDF15 induction during pathophysiologic conditions also suppresses appetite. The present review will briefly introduce the discovery of GDF15 and describe the different contexts under which GDF15 is induced, focusing on its induction during mitochondrial dysfunction. We will further discuss the metabolic role of GDF15 under various pathophysiological conditions and conclude with possible therapeutic applications.

Citations

Citations to this article as recorded by  

• Growth differentiation factor-15 is an IFN-γ regulated mediator of infection-induced weight loss and the hepatic FGF21 response
  Jojo Reyes, Yanlin Zhao, Krushang Pandya, George S. Yap
  Brain, Behavior, and Immunity.2024; 116: 24.     CrossRef
• Biomarkers of disability worsening in inactive primary progressive multiple sclerosis
  Maria-Elizabeth Baeva, Isabelle Tottenham, Marcus Koch, Carlos Camara-Lemarroy
  Journal of Neuroimmunology.2024; 387: 578268.     CrossRef
• Tricarboxylic Acid Cycle Intermediates and Individual Ageing
  Natalia Kurhaluk
  Biomolecules.2024; 14(3): 260.     CrossRef
• The implicated role of GDF15 in gastrointestinal cancer
  Yingqi Xue, Yan Zhang, Yale Su, Jiangqi Zhao, Daoquan Yu, Yunju Jo, Jongkil Joo, Hyun Joo Lee, Dongryeol Ryu, Shibo Wei
  European Journal of Clinical Investigation.2024;[Epub]     CrossRef
• Correlation Between Growth Differentiation Factor-15 and Peripheral Neuropathy in Patients with Type 2 Diabetes Mellitus
  Yue Li, Yuhui Wang, Yonghong Cao, Xinxiu Zhang, Wu Dai, Yiran Zhao, Lei Zhang, Xiaofang Han
  Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 3019.     CrossRef
• A long‐acting GDF15 analog causes robust, sustained weight loss and reduction of food intake in an obese nonhuman primate model
  Songmao Zheng, David Polidori, Yuanping Wang, Brian Geist, Xiefan Lin‐Schmidt, Jennifer L. Furman, Serena Nelson, Andrea R. Nawrocki, Simon A. Hinke
  Clinical and Translational Science.2023; 16(8): 1431.     CrossRef
• GDF15 enhances body weight and adiposity reduction in obese mice by leveraging the leptin pathway
  Samuel N. Breit, Rakesh Manandhar, Hong-Ping Zhang, Michelle Lee-Ng, David A. Brown, Vicky Wang-Wei Tsai
  Cell Metabolism.2023; 35(8): 1341.     CrossRef
• Serum growth differentiation factor-15 (GDF-15) is a biomarker of cardiac manifestations in children with COVID-19
  Sally Raafat Ishak, Mona Mostafa El Ganzoury, Eman Mahmoud Fouda, Maha Ahmad Anwar, Amany Moustafa Kamal, Heba Mostafa Hamza, Nehad Ahmed Bakry
  European Journal of Medical Research.2023;[Epub]     CrossRef
• Understanding the molecular basis of anorexia and tissue wasting in cancer cachexia
  Eunbyul Yeom, Kweon Yu
  Experimental & Molecular Medicine.2022; 54(4): 426.     CrossRef
• Investigating the combination of plasma amyloid-beta and geroscience biomarkers on the incidence of clinically meaningful cognitive decline in older adults
  Wan-Hsuan Lu, Kelly Virecoulon Giudici, John E. Morley, Sophie Guyonnet, Angelo Parini, Geetika Aggarwal, Andrew D. Nguyen, Yan Li, Randall J. Bateman, Bruno Vellas, Philipe de Souto Barreto, Bruno Vellas, Sophie Guyonnet, Isabelle Carrié, Lauréane Brigit
  GeroScience.2022; 44(3): 1489.     CrossRef
• The Potential Role of Growth Differentiation Factor 15 in COVID-19: A Corollary Subjective Effect or Not?
  Ahmad O. Babalghith, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Michel De Waard, Jean-Marc Sabatier, Hebatallah M. Saad, Gaber El-Saber Batiha
  Diagnostics.2022; 12(9): 2051.     CrossRef
• Metformin and growth differentiation factor 15 (GDF15) in type 2 diabetes mellitus: A hidden treasure
  Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Athanasios Alexiou, Marios Papadakis, Eman Hassan Nadwa, Sarah M. Albogami, Mohammed Alorabi, Hebatallah M. Saad, Gaber El‐Saber Batiha
  Journal of Diabetes.2022; 14(12): 806.     CrossRef
• Effects of Exercise Intervention on Mitochondrial Stress Biomarkers in Metabolic Syndrome Patients: A Randomized Controlled Trial
  Jae Seung Chang, Jun Namkung
  International Journal of Environmental Research and Public Health.2021; 18(5): 2242.     CrossRef
• Neurological & psychological aspects of Barth syndrome: Clinical manifestations and potential pathogenic mechanisms
  Melissa Olivar-Villanueva, Mindong Ren, Colin K.L. Phoon
  Mitochondrion.2021; 61: 188.     CrossRef
• The metabolic role of spermidine in obesity: Evidence from cells to community
  Yanee Choksomngam, Sintip Pattanakuhar, Nipon Chattipakorn, Siriporn C. Chattipakorn
  Obesity Research & Clinical Practice.2021; 15(4): 315.     CrossRef
• The Role of GDF15 as a Myomitokine
  Kornelia Johann, Maximilian Kleinert, Susanne Klaus
  Cells.2021; 10(11): 2990.     CrossRef